Experimental Alzheimer’s Drug Shows Promise

THURSDAY, April 17 (HealthDay News) -- A new analysis of a study on an experimental Alzheimer’s drug reinforces the notion that the compound is broadly effective at improving the cognitive function of mild to moderate Alzheimer’s patients.

MORE ON THIS TOPIC